Overview
My laboratory is interested in microbes that influence human health, both in the context of host-pathogen and host-commensal interactions. For many pathogens, and certainly for most commensal microbes, we have an incomplete molecular understanding of how host and microbial factors contribute to health and disease. My research group focuses on two experimental systems:
Chlamydia trachomatis infections are responsible for the bulk of sexually transmitted bacterial diseases and are the leading cause of infectious blindness (trachoma) in the world. Chlamydia resides within a membrane bound compartment (“inclusion”). From this location, the pathogen manipulates the cytoskeleton, inhibits lysosomal recognition of the inclusion, activates signaling pathways, re-routes lipid transport, and prevents the onset of programmed cell death. Our laboratory focuses on identifying and characterizing the bacterial factors that are secreted into the host cell cytoplasm to manipulate eukaryotic cellular functions. We use a combination of cell biology, biochemistry, genetics, genomics, proteomics and molecular biology to determining the function of virulence factors that reveal novel facets of the host-pathogen interaction. Our goal is to understand how these obligate intracellular bacterial pathogens manipulate host cellular functions to replicate, disseminate and cause disease, and in the process develop strategies to ameliorate the damage caused by these infections to the female reproductive organs.
Akkermansia muciniphila is prevalent member of the gut microbiota that proliferates in the mucus layers of our lower gastrointestinal tract and contribute to nutrient homeostasis and human immunological health. My research group developed genetic tools to characterize these microbes to define the mechanisms used to colonize the human gut and identify the molecular and cellular pathways that underscore Akkermansia's impact on immune homeostasis. In the process, we seek to engineer strains of Akkermansia that enhance their probiotic potential.
Current Appointments & Affiliations
Recent Publications
Epigenetic phase variation in the gut microbiome enhances bacterial adaptation.
Journal Article Cell Host Microbe · May 19, 2026 The human microbiome continuously adapts to variations in diet and host physiology. Epigenetic phase variation (ePV) mediated by bacterial DNA methylation can generate phenotypic heterogeneity within clonal populations. ePVs have been characterized in huma ... Full text Link to item CitePathobiont-triggered induction of goblet cell response drives regional susceptibility to inflammatory bowel disease.
Journal Article J Clin Invest · April 1, 2026 The gastrointestinal tract varies in structure and function by region, yet the drivers of region-specific inflammatory disease remain elusive. Here, a TNF-overexpressing murine model (TnfΔARE/+) of Crohn's disease (CD) was used to investigate how pathobion ... Full text Link to item CiteRecent Grants
Mechanisms of mucin binding and acquisition by Akkermansia
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2031Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMEAdvisor · Awarded by National Institutes of Health · 2010 - 2030Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation
ResearchPrincipal Investigator · Awarded by City of Hope · 2024 - 2029View All Grants